CZECANCA consortium
Assertion criteria
Level: Assertion criteria not provided
Summary of submissions to ClinVar
Total submissions: 251
Gene
| Gene | Submissions | Last Updated |
|---|---|---|
| ATM | 15 | Feb 21, 2023 |
| BARD1 | 5 | Feb 21, 2023 |
| BRCA1 | 62 | Feb 21, 2023 |
| BRCA2 | 60 | Feb 21, 2023 |
| BRIP1 | 11 | Feb 21, 2023 |
| C11orf65 | 10 | Feb 21, 2023 |
| CHEK2 | 15 | Feb 21, 2023 |
| DCTN5 | 1 | Jun 13, 2019 |
| ERCC4 | 1 | May 11, 2021 |
| FANCE | 1 | May 11, 2021 |
| FANCG | 1 | May 11, 2021 |
| FH | 1 | Sep 1, 2022 |
| HOXB13 | 1 | May 11, 2021 |
| LOC126862571 | 11 | May 11, 2021 |
| LOC129390903 | 1 | Jun 13, 2019 |
| MLH1 | 9 | Feb 21, 2023 |
| MSH2 | 7 | Feb 21, 2023 |
| MSH6 | 14 | Feb 21, 2023 |
| NBN | 8 | Sep 1, 2022 |
| PALB2 | 8 | Feb 21, 2023 |
| PMS2 | 1 | Sep 1, 2022 |
| POLD1 | 1 | May 11, 2021 |
| PTEN | 2 | Feb 21, 2023 |
| RAD50 | 8 | Sep 1, 2022 |
| RAD51C | 7 | Feb 21, 2023 |
| RAD51D | 7 | Jun 13, 2019 |
| RAD51L3-RFFL | 7 | Jun 13, 2019 |
| RET | 1 | Sep 1, 2022 |
| TP53 | 5 | May 11, 2021 |
Condition
| Name | Submissions | Last Updated |
|---|---|---|
| Breast and/or ovarian cancer | 168 | Jun 13, 2019 |
| Carcinoma of pancreas | 29 | May 11, 2021 |
| Endometrial carcinoma | 32 | Feb 21, 2023 |
| Hepatocellular carcinoma | 7 | Sep 1, 2022 |
| Uterine corpus cancer | 15 | Feb 21, 2023 |